Recent Finacing
Recent Raise
ProVascTec is a UCC spin-out developing PulseCLTI, a stem-cell–based, device-enabled therapy to restore blood flow in patients with critical limb-threatening ischemia.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor
